Navigation Links
Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World
Date:1/5/2009

er Toothbrush ($21.99) are sold at mass retail, drug and grocery stores nationwide (suggested retail prices). Actual pricing is at the sole discretion of retailers. For more information, visit www.crest.com and www.oralb.com.

About OPERATION SMILE

Founded in 1982 by Dr. William P. Magee, Jr. and his wife, Kathleen S. Magee, Operation Smile is a worldwide children's medical charity headquartered in Norfolk, Virginia. Since its founding, Operation Smile volunteers have treated more than 120,000 children born with cleft lips, cleft palates and other facial deformities and the organization currently has a presence in 51 countries. For more information, visit www.operationsmile.org.

ABOUT Crest

As a trusted leader in oral health, Crest helps consumers maintain healthy, beautiful smiles for life. Crest is committed to building on its history of developing innovative oral care products that meet the needs of consumers around the world. Since 1955 when Crest introduced the first fluoride toothpaste proven effective, it is estimated that Crest has helped prevent more than half a billion cavities in the United States alone. Crest also was the first toothpaste to secure the ADA Seal of Acceptance. Today Crest offers a family of products including toothpastes, toothbrushes, mouthrinses, floss and whitening treatments. Please visit www.crest.com for more product information, dental hygiene tips, special offers, promotions and more.

ABOUT ORAL-B

The Oral-B brand is a worldwide leader in the $5 billion oral care market. Part of Procter & Gamble, the brand includes manual and power
'/>"/>

SOURCE Procter & Gamble (P&G)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cedars-Sinai Board of Governors to Honor Ryan Seacrest & John Bendheim at Annual Road To A Cure Gala
2. Video: America Votes Crest Whitening Expressions Is FanTaste-ic!
3. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
4. VIDEO from Medialink and Crest: Crest and Oral-B Help Smiles Stay Healthy for a More Youthful You
5. Crestline Has Access to Hundreds of Thousands of Items
6. Grubb & Ellis Healthcare REIT Acquires SouthCrest Medical Plaza in Stockbridge, Ga.
7. Protect Yourself From Teeth to Toes! Lindsay Price and Crest Whitestrips Daily Whitening + Tartar Protection Partner to Empower Women for the 9th Annual National Womens Health Week
8. Crest(R) SPINBRUSH(R) Oral Hygiene Survey Reveals "Nothin but the Tooth"
9. CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
10. Samantha Harris and Oral-B Satin Floss Partner to Share Smiles
11. New Oral-B(R) Triumph(TM) With SmartGuide(TM) is the First Power Toothbrush With a Wireless Display
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 1NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 2NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 3NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 4SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 1SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 2SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 3SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 4Terumo Cardiovascular Systems Initiates U S Clinical Trial for Anaconda 28TM 29 AAA Stent Graft System 4777 1Terumo Cardiovascular Systems Initiates U S Clinical Trial for Anaconda 28TM 29 AAA Stent Graft System 4777 2